Travere Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 96.6% | -43.6% | -35.9% |
| FY2017 | 97.7% | -34.7% | -38.6% |
| FY2018 | 96.6% | -48.7% | -62.5% |
| FY2019 | 97.0% | -78.3% | -83.5% |
| FY2020 | 96.9% | -88.8% | -85.4% |
| FY2021 | 97.1% | -151.3% | -136.6% |
| FY2022 | 96.0% | -292.2% | -254.4% |
| FY2023 | 92.1% | -267.2% | -76.7% |
| FY2024 | 96.7% | -138.9% | -137.9% |
| FY2025 | 97.9% | -12.8% | -5.2% |